Conclusions The present analysis expanded on the results of the SUSTAIN 3 and SUSTAIN 7 clinical trials, which showed that once-weekly semaglutide was more efficacious than exenatide ER and dulaglutide 0.75 mg and 1.5 mg at bringing patients to each of three clinically relevant endpoints covering glycemic control, hypoglycemia, and weight loss
Why what to eat on GLP-1s still matters First up, yes, GLP-1s can reduce cravings and appetite
Stickel F, Kessebohm K, Weimann R, Seitz HK
This method is commonly used to treat conditions like methemoglobinemia (a blood disorder) or to support certain medical procedures
One case-control study reported that selenium-responsive glutathione peroxidase 1 (GPx1) activity was significantly lower in Keshan patients compared to healthy individuals
Its one of the only antioxidants that your body produces naturally